Cargando…
Fractional Excretion of Phosphate (FeP) Is Associated with End-Stage Renal Disease Patients with CKD 3b and 5
Background: The perturbation of phosphate homeostasis portends unfavorable outcomes in chronic kidney disease (CKD). However, the absence of randomized clinical trials (RCT) fuels the discussion of whether phosphate or some other phosphorous-related factor(s) such as fibroblast growth factor 23 (FGF...
Autores principales: | Bellasi, Antonio, Di Micco, Lucia, Russo, Domenico, De Simone, Emanuele, Di Iorio, Mattia, Vigilante, Raffaella, Di Lullo, Luca, Di Iorio, Biagio Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678389/ https://www.ncbi.nlm.nih.gov/pubmed/31336909 http://dx.doi.org/10.3390/jcm8071026 |
Ejemplares similares
-
QT interval in CKD and haemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2013) -
Phosphate Metabolism Modulation in Chronic Kidney Disease: When, How and to What Extent?
por: Bellasi, Antonio, et al.
Publicado: (2014) -
Very Low Protein Diet for Patients with Chronic Kidney Disease: Recent Insights
por: Di Micco, Lucia, et al.
Publicado: (2019) -
Chronic Kidney Disease: The Silent Epidemy
por: Bellasi, Antonio, et al.
Publicado: (2019) -
Correction of metabolic acidosis improves insulin resistance in chronic kidney disease
por: Bellasi, Antonio, et al.
Publicado: (2016)